PRQR
ProQR TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade F from latest DB weights. Momentum 33.5 / Value 41.2
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
34
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $9.06
Why
Momentum34 · Δ7d -
Value41 · Δ7d 0.0
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
No dated catalyst is available.
Lead driver: Value · See fundamentals
Momentum
34
25% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
75% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 33.5 / Value 41.2
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$266.51M
Beta
0.20
Shares Out
138.09M
P/E (TTM) · Derived
-4.3
P/S (TTM)
11.41
P/FCF (TTM) · Derived
-3.45
Rev YoY
+135.4%
EPS YoY
-29.5%
Gross Margin
+85.0%
Op Margin
-234.1%
Net Debt
-$92.1M
Current Ratio
3.49
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data